Literature DB >> 12957288

The hypoxic response of tumors is dependent on their microenvironment.

Barbara Blouw1, Hanqiu Song, Tarik Tihan, Jenel Bosze, Napoleone Ferrara, Hans Peter Gerber, Randall S Johnson, Gabriele Bergers.   

Abstract

To reveal the functional significance of hypoxia and angiogenesis in astrocytoma progression, we created genetically engineered transformed astrocytes from murine primary astrocytes and deleted the hypoxia-responsive transcription factor HIF-1alpha or its target gene, the angiogenic factor VEGF. Growth of HIF-1alpha- and VEGF-deficient transformed astrocytes in the vessel-poor subcutaneous environment results in severe necrosis, reduced growth, and vessel density, whereas when the same cells are placed in the vascular-rich brain parenchyma, the growth of HIF-1alpha knockout, but not VEGF knockout tumors, is reversed: tumors deficient in HIF-1alpha grow faster, and penetrate the brain more rapidly and extensively. These results demonstrate that HIF-1alpha has differential roles in tumor progression, which are greatly dependent on the extant microenvironment of the tumor.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12957288     DOI: 10.1016/s1535-6108(03)00194-6

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  146 in total

1.  The tumour suppressor C/EBPδ inhibits FBXW7 expression and promotes mammary tumour metastasis.

Authors:  Kuppusamy Balamurugan; Ju-Ming Wang; Hsin-Hwa Tsai; Shikha Sharan; Miriam Anver; Robert Leighty; Esta Sterneck
Journal:  EMBO J       Date:  2010-11-12       Impact factor: 11.598

2.  Advanced glycation end product (AGE)-receptor for AGE (RAGE) signaling and up-regulation of Egr-1 in hypoxic macrophages.

Authors:  Yunlu Xu; Fatouma Toure; Wu Qu; Lili Lin; Fei Song; Xiaoping Shen; Rosa Rosario; Joel Garcia; Ann Marie Schmidt; Shi-Fang Yan
Journal:  J Biol Chem       Date:  2010-05-27       Impact factor: 5.157

Review 3.  Nanoparticle Probes for the Detection of Cancer Biomarkers, Cells, and Tissues by Fluorescence.

Authors:  Alyssa B Chinen; Chenxia M Guan; Jennifer R Ferrer; Stacey N Barnaby; Timothy J Merkel; Chad A Mirkin
Journal:  Chem Rev       Date:  2015-08-27       Impact factor: 60.622

4.  The selective hypoxia inducible factor-1 inhibitor PX-478 provides in vivo radiosensitization through tumor stromal effects.

Authors:  David L Schwartz; Garth Powis; Arun Thitai-Kumar; Yi He; James Bankson; Ryan Williams; Robert Lemos; Junghwan Oh; Andrei Volgin; Suren Soghomonyan; Ryuichi Nishii; Mian Alauddin; Uday Mukhopadhay; Zhenghong Peng; William Bornmann; Juri Gelovani
Journal:  Mol Cancer Ther       Date:  2009-04       Impact factor: 6.261

Review 5.  Use of bevacizumab in recurrent glioblastoma.

Authors:  Ashley Ghiaseddin; Katherine B Peters
Journal:  CNS Oncol       Date:  2015-04-23

Review 6.  Antiangiogenic therapy: impact on invasion, disease progression, and metastasis.

Authors:  John M L Ebos; Robert S Kerbel
Journal:  Nat Rev Clin Oncol       Date:  2011-03-01       Impact factor: 66.675

7.  Transcriptional regulation of urokinase-type plasminogen activator receptor by hypoxia-inducible factor 1 is crucial for invasion of pancreatic and liver cancer.

Authors:  Peter Büchler; Howard A Reber; James S Tomlinson; Oliver Hankinson; Georgis Kallifatidis; Helmut Friess; Ingrid Herr; Oscar J Hines
Journal:  Neoplasia       Date:  2009-02       Impact factor: 5.715

8.  Vasculostatin inhibits intracranial glioma growth and negatively regulates in vivo angiogenesis through a CD36-dependent mechanism.

Authors:  Balveen Kaur; Sarah M Cork; Eric M Sandberg; Narra S Devi; Zhaobin Zhang; Philip A Klenotic; Maria Febbraio; Hyunsuk Shim; Hui Mao; Carol Tucker-Burden; Roy L Silverstein; Daniel J Brat; Jeffrey J Olson; Erwin G Van Meir
Journal:  Cancer Res       Date:  2009-01-27       Impact factor: 12.701

9.  The role of tumor cell-derived connective tissue growth factor (CTGF/CCN2) in pancreatic tumor growth.

Authors:  Kevin L Bennewith; Xin Huang; Christine M Ham; Edward E Graves; Janine T Erler; Neeraja Kambham; Jonathan Feazell; George P Yang; Albert Koong; Amato J Giaccia
Journal:  Cancer Res       Date:  2009-02-01       Impact factor: 12.701

10.  HIF-1alpha induces cell cycle arrest by functionally counteracting Myc.

Authors:  Minori Koshiji; Yukio Kageyama; Erin A Pete; Izumi Horikawa; J Carl Barrett; L Eric Huang
Journal:  EMBO J       Date:  2004-04-08       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.